CA2860065A1 - Method and system for combined ultrasound treatment - Google Patents

Method and system for combined ultrasound treatment Download PDF

Info

Publication number
CA2860065A1
CA2860065A1 CA2860065A CA2860065A CA2860065A1 CA 2860065 A1 CA2860065 A1 CA 2860065A1 CA 2860065 A CA2860065 A CA 2860065A CA 2860065 A CA2860065 A CA 2860065A CA 2860065 A1 CA2860065 A1 CA 2860065A1
Authority
CA
Canada
Prior art keywords
region
interest
tissue
ultrasound
effect
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2860065A
Other languages
French (fr)
Other versions
CA2860065C (en
Inventor
Michael H. Slayton
Inder Raj S. Makin
Peter G. Barthe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guided Therapy Systems LLC
Original Assignee
Guided Therapy Systems LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guided Therapy Systems LLC filed Critical Guided Therapy Systems LLC
Publication of CA2860065A1 publication Critical patent/CA2860065A1/en
Application granted granted Critical
Publication of CA2860065C publication Critical patent/CA2860065C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H23/00Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms
    • A61H23/02Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms with electric or magnetic drive
    • A61H23/0245Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms with electric or magnetic drive with ultrasonic transducers, e.g. piezoelectric
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N7/00Ultrasound therapy
    • A61N7/02Localised ultrasound hyperthermia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00Diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/44Constructional features of the ultrasonic, sonic or infrasonic diagnostic device
    • A61B8/4444Constructional features of the ultrasonic, sonic or infrasonic diagnostic device related to the probe
    • A61B8/4472Wireless probes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00Diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/48Diagnostic techniques
    • A61B8/483Diagnostic techniques involving the acquisition of a 3D volume of data
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2201/00Characteristics of apparatus not provided for in the preceding codes
    • A61H2201/50Control means thereof
    • A61H2201/5007Control means thereof computer controlled
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N7/00Ultrasound therapy
    • A61N2007/0004Applications of ultrasound therapy
    • A61N2007/0008Destruction of fat cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N7/00Ultrasound therapy
    • A61N2007/0073Ultrasound therapy using multiple frequencies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N7/00Ultrasound therapy
    • A61N2007/0078Ultrasound therapy with multiple treatment transducers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N7/00Ultrasound therapy

Abstract

A non-invasive method and system for combined ultrasound treatment are provided. An exemplary combined ultrasound treatment system comprises a transducer configured to deliver ultrasound energy to provide two or more energy effects to a region of interest. The energy effects facilitate the initiation of one or more responses in the region of interest. In accordance with an exemplary embodiment of the present invention, a transducer is configured to deliver energy over varying temporal and/or spatial distributions in order to provide energy effects and initiate responses in a region of interest.

Description

METHOD AND SYSTEM FOR COMBINED ULTRASOUND TREATMENT
Field of Invention This invention generally relates to a therapeutic ultrasound method and system, and Background of the Invention Many conventional applications of energy to superficial human tissue employ ablative or non-ablative lasers, radio frequency, or ultrasound. Some recent examples of Patent No. 6,626,854 (employing ultrasound for lipolysis), and in Klopotek, U.S Patent Nos. 6,113,559 and 6,325,769 (employing ultrasound for collagen reformation).
While surface ablative lasers cause severe trauma to the upper layer of the skin, such as derrnis skin, the medical efficacy and results are significant. Non-ablative lasers and RF energy sources do not cause significant trauma to the upper surface of the skin, but the efficacy of such sources is low, and with the end results being less than satisfactory.
During the last decade attempts have been made to use ultrasound in lipolysis investigative attempts may show potential promise of fat destruction in volume, the objective of such ultrasound procedures is solely to reduce the thickness of the fat layer rather than any rejuvenation of the initial superficial layer.
Currently, some suggested therapy methods aim at collagen reformation as a regeneration as a primary target and biological response. However, specific targeting of collagen reformation may not be the only or even a critical factor in tissue rejuvenation.
For example diode lasers and intense pulsed light pp, which can target collagen with very high specificity, are generally yielding mixed or low efficacy results.
Moreover, RF
and has difficulties with the selectivity and placement of the energy that fundamentally is dependent on the electrical impedance of the treated tissue.

S1110.1ilarY of the Invention In accordance with various aspects of the present invention, a non-invasive method and system for combined ultrasound treatment are provided. An exemplary combined ultrasound treatment method and system comprises a transducer configured to deliver ultrasound energy to provide two or more energy effects to a region of interest. The energy effects facilitate the initiation of one or more responses in the region of interest In accordance with an exemplary embodiment of the present invention, a transducer is configured to deliver energy over varying temporal and/or spatial distributions in order to provide energy effects and initiate responses in a region of interest_ For example, an exemplary transducer is operated under one or more frequency ranges to provide two or more energy effects and initiate one or more responses in the region of interest. In addition, the transducer can also be configured to deliver planar, defocused and/or focused energy to a region of interest to provide two or more energy effects and to initiate one or more biological responses.
Brief Description of the Drawing Figures The subject matter of the invention is particularly pointed out and distinctly claimed in the concluding portion of the specification. The invention, however, both as to organization and method of operation, may best be understood by reference to the following description taken in conjunction with the claims and the accompanying drawing figures, in which like parts may be referred to by like numerals:
Fig. 1 illustrates a block diagram of an exemplary combined ultrasound treatment system in accordance with an exemplary embodiment of the present invention;
Fig. 2 illustrates a block diagram of an exemplary combined ultrasound treatment system in accordance with an exemplary embodiment of the present invention;
Fig. 3 illustrates a cross-sectional diagram of an exemplary transducer in accordance with an exemplary embodiment of the present invention;
Figs. 4A, 4B, 4C and 4D illustrate cross-sectional diagrams of an exemplary transducer for imaging in accordance with various exemplary embodiments of the present invention;
Fig. 5 is an exemplary embodiment of a transducer configured as a two-dimensional array for ultrasound treatment;
2 Figs. 6A, 6B and 6C are flowcharts of methods for combined ultrasound treatment in accordance with exemplary embodiments of the present invention; and Figs. 7A-7C illustrate exemplary embodiments of an imaging, therapy and tissue parameter monitoring subsystems in accordance with the present invention.
Detailed Description The present invention may be described herein in terms of various components and processing steps. It should be appreciated that such components and steps may be realized by any number of hardware components configured to perform the specified functions.
For example, the present invention may be configured with various medical treatment devices, visual imaging and display devices, input terminals and the like, which may carry out a variety of functions under the control of one or more control systems or other control devices. In addition, the present invention may be practiced in any number of medical or treatment contexts and that the exemplary embodiments relating to a method and system for combined ultrasound treatment as described herein are merely a few of the exemplary applications for the invention. For example, the principles, features and methods discussed may be applied to any medical or other tissue or treatment application.
In accordance with various aspects of the present invention, a non-invasive method and system for combined ultrasound treatment are provided. An exemplary therapeutic method and system comprise a transducer system configured to deliver one or more energy fields to one or more regions of interest within a patient. The energy field or fields may provide two or more effects to initiate one or more responses to the region or regions of interest.
For example, with reference to an exemplary embodiment illustrated in Fig. 1, an exemplary system 100 for combined ultrasound treatment includes a transducer 102 that can be configured via control system 112 to provide one or more energy fields 104 to achieve two or more biological effects 106 for rejuvenation and/or treatment of a region of interest (ROI) 110. Effects 104 can initiate and/or stimulate two or more biological responses 108 within ROI 110.
For example, a combined ultrasound treatment system may be achieved by providing ultrasound treatment under various temporal and/or spatial regimes to initiate and combine a plurality of biological effects to provide one or more responses to a region or regions of interest. By providing ultrasound treatment under various temporal and/or
3 spatial regimes, energy fields 104 can comprise ultrasound energy of any acoustic frequency level. For example, energy fields 104 can comprise a low frequency acoustical energy, an increased intensity homogeneous or uniform ultrasound field of energy, a high-frequency acoustical energy, ultra-high frequency acoustical energy, and/or any other level of acoustical energy. Selecting the frequency for operation can be based on the type of treatment desired for an application. Energy fields 104 can also be focused, defocused, and/or made substantially planar by transducer 102 to provide a plurality of effects 106.
For example, a substantially planar energy field 104 can provide a heating and/or pretreatment effect, a focused energy field 104 can provide an ablative or hyperthermal effect, and a defocused energy field can provide diffused heating effects.
Effects 106 can comprise any tissue effect configured for initiating and/or stimulating two or more biological responses 108 in ROI 110, including but not limited to, thermal and non-thermal streaming, cavitational (including stable cavitation by low level ultrasound of 0.1 to 1 W/cm2 in the megahertz frequency range), hydrodynamic, ablative, hemostatic, diathermic, and/or resonance-induced tissue effects. A combination of two or more effects to produce one or more responses can produce a higher efficacy and faster rejuvenation of the skin without causing chronic injury to the human tissue.
For example, a combination of variable temporal and/or spatial depositions of ultrasound energy can be provided to tissue underneath the stratum corneum without chronic injury to epidermis and stratum corneum.
Response(s) 108 initiated and/or stimulated by effects 106 can include any biological response initiated and/or stimulated by energy effects, such as, for example: 1) hemostasis, including that stimulated from highly concentrated ultrasound beams, 2) subsequent revaseularizationiangiogenesis, such as that generated from high frequency applications of approximately 2 MHz to 7 MHz or more, 3) growth of interconnective tissue, 4) reformation and/or ablation of existing tissue such as fat, collagen and others, 5) increased cell permeability that may facilitate the possibility of stimulated gene or medication therapy to tissue, and/or increased permeability of certain tissues to a variety of medications initiated by ultrasound frequencies 10 kHz to 10 MHz, 6) enhanced delivery and/or activation of medicants, 7) stimulation of protein synthesis and/or 8) any other possible tissue response. Exemplary ablative responses of focused ultrasound are demonstrated in U.S. Patent Nos. 6,050,943 and 6,500,121, having at least one common inventor and a common Assignee as the present application. Thus, for example, a low
4 intensity dispersed ultrasOund field can be generated to provide for angiogenesis, an increased intensity homogeneous or uniform ultrasound field can be generated to provide for diathermy that increases the rate of healing and rejuvenation, and/or high intensity focused and/or unfocused beams can be generated to provide for temporary ablative and hemostatic effects in a variety of depth and positions of human tissue, whereby a summation or a combined effect of rejuvenation is created by combining ultrasound energy fields.
In providing treatment, transducer 102 may provide therapy, imaging and/or temperature or other tissue parameter monitoring to a region of interest 110.
For example, as will be discussed in more detail later in accordance with an exemplary embodiment illustrated in Figures 7A-7C, a transducer 700 can be configured for therapy, imaging and temperature monitoring within the same transducer. Region of interest 110 can comprise an inner treatment region, a superficial region, a subcutaneous region of interest and/or any other region of interest in between an inner treatment region, a superficial region, and/or a subcutaneous region within a patient. While only one region of interest 110 is depicted, transducer 102 may be configured to treat a plurality of regions of interest.
For example, an exemplary combined transducer system can comprise a transducer configured to provide highly concentrated ultrasound energy to provide effects that initiate and/or stimulate a hemostasis response. An exemplary combined transducer system can also comprise a transducer configured to provide medium frequency range ultrasound energy, ranging from approximately 2 MHz to 7 1\4:11z, to provide effects that initiate and/or stimulate responses such as additional revascularization/angiogenesis treatment, among others. The exemplary therapeutic transducer system can also comprise a transducer configured to deliver energy that provides a non-thermal streaming effect to initiate and/or stimulate a tissue regeneration response. In addition, a ti ansducer may also be configured to initiate and/or stimulate a stable cavitation response through by effects provided from the delivery of low-level ultrasound energy.
Transducer 102 can comprise one or more transducers configured for facilitating treatment. Transducer 102 can also comprise one or more transduction elements.
The transduction elements can comprise a piezoelectrically active material, such as lead zirconante titanate (PZT), or any other piezoelectrically active material, such as a piezoelectric ceramic, crystal, plastic, and/or composite materials, as well as lithium niobate, lead titanate, barium titanate, and/or lead metaniobate. In addition to, or instead
5 of, a piezoelectrically active material, transducer 102 can comprise any other materials configured for generating radiation and/or acoustical energy such as capacitively coupled transducers or other acoustic sources. Transducer 102 can also comprise one or more matching and/or backing layers configured along with the transduction element such as coupled to the piezoelectrically active material. Transducer 102 can also be configured with single or multiple damping elements along the transduction element.
In accordance with an exemplary embodiment, the thickness of the transduction element of transducer 102 can. be configured to be unifoini. That is, the transduction element can be configured to have a thickness that is substantially the same throughout.
In accordance with another exemplary embodiment, the transduction element can also be configured with a variable thickness, and/or as a multiple damped device. For example, the transduction element of transducer 102 can be configured to have a first thickness selected to provide a center operating frequency of a lower range, for example from approximately 1 kHz to 3 MHz. The transduction element can also be configured with a second thickness selected to provide a center operating frequency of a higher range, for example from approximately 3 to 100 MHz or more.
Transducer 102 can be configured as a single broadband transducer excited with at least two or more frequencies to provide an adequate output for generating a desired response 108. Transducer 102 can also be configured as two or more individual transducers, wherein each transducer comprises a transduction element. The thickness of the transduction elements can be configured to provide center-operating frequencies in a desired treatment range. For example, transducer 102 can comprise a first transducer configured with a first transduction element having a thickness corresponding to a center frequency range of approximately 1 MHz to 3 MHz, and a second transducer configured with a second transduction element having a thickness corresponding to a center frequency of approximately 3 MHz to 100 MHz or more. Various other ranges of thickness for a first and/or second transduction element can also be realized.
An exemplary transducer 102 can be suitably controlled and operated in various manners. For example, with reference to an exemplary embodiment depicted in Fig. 2, an exemplary combined ultrasound treatment system 200 may comprise a control system 208 coupled to a transducer 202. Control system 208 may be configured to facilitate control and operation of transducer 202 for providing combined ultrasound treatment to a region of interest 210. To facilitate controlled movement, in accordance with an exemplary
6 embodiment, control system 208 may also be configured with a motion control and position encoding system 212 configured to facilitate mechanical scanning by transducer 202 for providing more flexible ultrasound treatment of a region of interest 210. Motion control and position encoding system 212 can comprise any conventional motion control system, with various types of feedback arrangements in addition to or instead of position encoding. For example, motion control and position encoding system 212 can also comprise one or more feedback configurations or sources of information as disclosed in U.S. Pat. App. "System and Method for Variable Depth Ultrasound Treatment", filed on September 15, 2004, having at least one common inventor and a common Assignee as the present application, and incorporated herein by reference. The position-encoding configuration can comprise any position encoder system now known or hereinafter devised.
Control system 208 may comprise a processor, a display, and/or one or more input devices. The processor may comprise a personal computer, a Unix system, or any other conventional processing unit. An exemplary display may comprise a monitor, LCD
screen, or any other device configured to display an image. The exemplary display may be configured to provide imaging in any manner now known or hereinafter devised.
For example, transducer 202 may use pulse-echo imaging to obtain an image of a ROI
210.
That image may then be transmitted to the display via one or more coupling mechanisms.
An input/output device may comprise a keyboard, a mouse, a touch-screen, or any other device for the input and/or output of information. The information from the input device and images displayed may be received or transmitted in any format, such as manually, by analog device, by digital device, and/or by any other mechanisms. The various devices of control system 208, including any processor, display, and/or input device, can be coupled together in any manner. By coupling, the various devices may be directly connected to each other or may be connected through one or more other devices or components that allow a signal to travel to/from one component to another. The various coupling components for the devices comprising control system 208 can include but are not limited to the internet, a wireless network, a conventional wire cable, an optical cable or connection through air, water, or any other medium that conducts signals, and any other coupling device or medium.
Control system 208 can also be coupled to transducer 202 in various manners.
In accordance with an exemplary embodiment, electrical leads may couple together control
7 system 208 and transducer 202. The, electrical leads may be configured to enable power to be transmitted to. and signals received from transducer 202, and can comprise any wiring type, configuration and/or arrangement for use with ultrasound transducers.
Transducer 202 may also be coupled to electrical leads in various manners. For example, while Fig. 2 depicts electrical leads coupled to only one end of transducer 202, electrical leads may also be coupled together on an opposite end, or any other location along transducer 202.
Control system 208 may also be configured integral to transducer 202, for example connected together as a single structure with suitable electrical and/or transmission connections in between.
To facilitate coupling of transucer 202 to region of interest 210, transducer 202 can further comprise a coupling system 204 configured for acoustic coupling of ultrasound energy and signals. Coupling system 204 may facilitate such coupling through use of various coupling mediums, including air and other gases, water and other fluids, gels, solids, and/or any combination thereof, or any other medium that allows for signals to be transmitted between transducer 202 and region of interest 210. In addition to providing a coupling function, in accordance with an exemplary embodiment, coupling system 204 can also be configured for providing temperature control during the treatment application. For example, coupling system 204 can be configured for controlled cooling of an interface surface or region between transducer 202 and region of interest 210 by suitably controlling the temperature of the coupling medium. The suitable temperature for such coupling medium can be achieved in various manners, and utilize various feedback systems, such as thermocouples, thennistors or any other device or system configured for temperature measurement of a coupling medium. Such controlled cooling can be configured to further facilitate spatial and/or thermal energy control of combined ultrasound treatment system 200.
As discussed above, an exemplary transducer 202 can be configured in various manners for providing combined ultrasound treatment to a region-of-interest 210. For example, with reference to an exemplary embodiment depicted in Fig. 3, transducer 302 can be configured as an acoustic array to facilitate phase focusing. That is, transducer 302 can be configured as an array of electronic apertures that may be operated by a variety of phases via variable electronic time delays. By the term "operated," the electronic apertures of transducer 302 may be manipulated, driven, used, and/or configured to produce and/or deliver an energy beam corresponding to the phase variation caused by the electronic time
8 delay. For example, these phase variations an be used to deliver defocused beams, planar beams, and/or focused beams, each of which may be used in combination to achieve different physiological effects in region of interest (ROI) 310. Transducer 302 may additionally be configured with any software and/or other hardware for generating, producing and or driving a phased aperture array with one or more electronic time delays.
Transducer 302 can be configured to produce and/or deliver lower and/or higher frequencies to treat ROT 310. ROT 310 can also comprise one or more additional regions of interest. For example, ROI 310 can comprise a superficial layer 312, a subcutaneous layer 314, and/or an inner region 322 of a patient. ROT 310 can also comprise any area between superficial layer 312 and inner region 322 or between subcutaneous layer 314 and inner region 322. Inner region 322 is located at a depth 324 within tissue layers of a patient. For example, depth 324 can range from approximately 0 mm to 40 mm within a patient, wherein the approximately 0 mm range comprises the outer surface of superficial layer 312 of the patient. In other words, superficial layer 312 of the patient can comprise any area on or near the surface of the patient. Treatment by transducer 302 may include treatment of any of superficial, subcutaneous and/or inner region of a patient, as well as any combination of. those regions of a patient In accordance with one exemplary embodiment, treatment of first ROI 310 may be facilitated by use of transducer 302 driven at low frequencies, for example, from approximately 1 MHz to 3 MHz.
With reference again to an exemplary embodiment depicted in FIG. 3, transducer 302 may also be configured to treat one or more additional regions of interest (ROT) 320.
In accordance with an exemplary embodiment, additional ROI 320 may be located within ROI 310. Treatment of additional ROT 320 may be facilitated by use of transducer 302 operating from low to ultra-high frequencies, for example, from below approximately 3 MHz up to 100 MHz or more. While FIG. 3 depicts additional ROI 320 located within inner region 322, in accordance with other exemplary embodiments, additional may be located anywhere within first ROI 310, including within inner region 322, superficial region 312 and/or subcutaneous region 314.
By treatment of ROI 310, with momentary reference again to Figure 1, transducer 302 may be configured to deliver one or more energy fields 104 to provide a plurality of effects 106 to initiate and/or stimulate one or more biological responses 108, such as, for example, diathermy, hemostasis, revascularization, angiogenesis, growth of interconnective tissue, tissue reformation, ablation of existing tissue, protein synthesis
9 and/or enhanced cell permeability., Two or more of these biological responses may be combined to facilitate rejuvenation and/or treatment of superficial tissue.
Transducer 302 may also be configured for imaging and/or temperature or other tissue parameter monitoring of ROT 310 in order to facilitate optimal treatment results.
Transducer 302 can also be configured to provide focused treatment to one or more regions of interest using moderate frequencies, ranging from approximately 750 kHz to MHz. In order to provide focused treatment, transducer 302 can be configured with one or more variable depth devices to facilitate treatment. For example, transducer 302 may be configured with variable depth devices disclosed in U.S. Patent Application No.
10 10/944,500, entitled "System and Method for Variable Depth Ultrasound", filed on September 16, 2004, having at least one common inventor and a common Assignee as the present application. . In addition, transducer 302 can also be configured to treat one or more additional ROT 320 through the enabling of sub-harmonics or pulse-echo imaging, as disclosed in U.S. Patent Application No.
10/944,499, entitled "Method and System for Ultrasound Treatment with a Multi-directional Transducer", filed on September 16, 2004, having at least one common inventor and a common Assignee as the present application.
Moreover, any variety of mechanical lenses or variable focus lenses, e.g.
liquid-filled lenses, may also be used to focus and or defocus the sound field. For example, with reference to exemplary embodiments depicted in Figs. 4A and 4B, transducer 402 may also be configured with an electronic focusing array 404 in combination with one or more transduction elements 406 to facilitate increased flexibility in treating ROT
410. Array 404 may be configured in a manner similar to transducer 302. That is, array 404 can be configured as an array of electronic apertures that may be operated by a variety of phases via variable electronic time delays, for example, ti, r2, r3 rj. By the term "operated,"
the electronic apertures of array 404 may be manipulated, driven, used, and/or configured to produce and/or deliver energy in a manner corresponding to the phase variation caused by the electronic time delay. For example, these phase variations can be used to deliver defocused beams, planar beams, and/or focused beams, each of which may be used in combination to achieve different physiological effects in ROT 410.
Transduction elements 406 may be configured to be concave, convex, and/or planar. For example, in an exemplary embodiment depicted in Fig. 4A, transduction elements 406A are configured to be concave in order to provide focused energy for treatment of ROT 410A. Additional pmboditnents are disclosed in U.S. Patent Application, 10/944,500 entitled "System and Method for Variable Dept Ultrasound".
In another exemplary embodiment, depicted in Fig. 413, transduction elements 406B can be configured to be substantially flat in order to provide substantially uniform energy to ROT 41013. While Figs. 4A and 413 depict exemplary embodiments with transduction elements 404 configured as concave and substantially flat, respectively, transduction elements 404 can be configured to be concave, convex, and/or substantially flat. In addition, transduction elements 404 can be configured to be any combination of concave, convex, and/or substantially flat structures. For example, a first transduction element can be configured to be concave, while a second transduction element can be configured to be substantially flat.
With reference to Figs. 4C and 4D, transducer 402 can also be configured as an annular array to provide planar, focused and/or defocused acoustical energy.
For example, in accordance with an exemplary embodiment, an annular array 400 can comprise a plurality of rings 412, 414, 416 to N. Rings 412, 414, 416 to N can be mechanically and electrically isolated into a set of individual elements, and can create planar, focused, or defocused waves. For example, such waves can be centered on-axis, such as by methods of adjusting corresponding transmit and/or receive delays, ti, r2, r3 r1\1.
An electronic focus can be suitably moved along various depth positions, and can enable variable strength or beam tightness, while an electronic defocus can have varying amounts of defocusing. In accordance with an exemplary embodiment, a lens and/or convex or concave shaped annular array 400 can also be provided to aid focusing or defocusing such that any time differential delays can be reduced. Movement of annular array 400 in one, two or three-dimensions, or along any path, such as through use of probes and/or any conventional robotic arm mechanisms, may be implemented to scan and/or treat a volume or any corresponding space within a region of interest.
In accordance with another exemplary embodiment, transducer 202 may be suitably diced in two-dimensions to form a two-dimensional array. For example, with reference to Fig. 5, an exemplary two-dimensional array 500 can be suitably diced into a plurality of two-dimensional portions 502. Two-dimensional portions 502 can be suitably configtired to focus on the treatment region at a certain depth, and thus provide respective slices 504 of the treatment region. As a result, the two-dimensional array 500 can provide a two-
11 dimensional slicing of the image, place of a treatment region, thus providing two-dimensional treatment.
In accordance with another exemplary embodiment, transducer 202 may be suitably configured to provide three-dimensional treatment. For example, to provide-three dimensional treatment of a region of interest, with reference again to Fig. 2, a three-dimensional system can comprise transducer 202 configured with an adaptive algorithm, such as, for example, one utilizing three-dimensional graphic software, contained in a control system, such as control system 208. The adaptive algorithm is suitably configured to receive two-dimensional imaging and temperature information relating to the region of interest, process the received information, and then provide corresponding three-dimensional imaging and temperature information. For example, transducer 202 may be configured with a 3D imaging and monitoring system as disclosed in U.S. Pat.
App.
10/193,491, entitled "Imaging, Therapy & Temperature Monitoring Ultrasonic System", filed on July 10, 2002, as well as disclosed in U.S. Pat. No. 6,036,646, entitled "Imaging, Therapy & Temperature Monitoring Ultrasonic System", also having at least one common inventor and a common Assignee as the present application.
In accordance with an exemplary embodiment, with reference again to Fig. 5, an exemplary three-dimensional system can comprise a two-dimensional array 500 configured with an adaptive algorithm to suitably receive 504 slices from different image planes of the treatment region, process the received information, and then provide volumetric information 506, e.g., three-dimensional imaging and temperature information.
Moreover, after processing the received information with the adaptive algorithm, the two-dimensional array 500 may suitably provide therapeutic heating to the volumetric region 506 as desired.
Alternatively, rather than utilizing an adaptive algorithm, such as three-dimensional software, to provide three-dimensional imaging and/or temperature information, an exemplary three-dimensional system can comprise transducer 202 configured within a probe arrangement to operate from various rotational and/or translational positions relative to a target region. For example, transducer 202 may be configured with a probe configuration, e.g., a manually operated or motorized probe configuration, as disclosed in U.S. Pat. No. 6,036,646, entitled "Imaging, Therapy & Temperature Monitoring Ultrasonic System", having some common inventors and a common Assignee as the present application. In addition to and/or alternatively,
12 transducer 202 may be -cOlfigured 'with a 3,D probe device disclosed in U.S.
Provisional Application No. 60/570,145, entitled "3D Data Acquisition Device for Ultrasound," filed on May 12, 2004, Irrespective of the type of transducer system utilized, the size of any acoustic single and/or two-dimensional arrays, individual transducer elements, and single or multiple elements may comprise a variety of sizes to achieve the desired acoustic field distributions, such as for example from a fraction of an acoustic wavelength in size, e.g., one that radiates sound and/or ultrasound over a broad angle, up to acoustic sources that are many wavelengths in breadth, e.g., one that projects sound and/or ultrasound in a more forward directional manner.
Moreover, the physiological effects created in tissue by the exemplary combined ultrasound systems are not only affected by the spatial distribution of energy, but also the temporal, e.g., time-varying, characteristics. Thus, each array, two-dimensional array, or single element or other transducer may also be 1) used at various transmit frequencies, such as from 20 kHz to 100 MHz, or even with single broadband pulses of energy, 2) used with varied transmit pulse lengths from a millisecond to continuous wave, e.g., for seconds, minutes, or longer, 3) used with varied pulse duty cycle from almost zero percent ON time to 100% ON time, and/or 4) used with various transmit power levels from microwatts to kilowatts, depending on the total desired energy and acoustic intensity levels.
Through operation of ultrasound system 200, a method for combined ultrasound treatment can be realized that can facilitate effective and efficient therapy without creating chronic injury to human tissue. For example, with reference to Figs. 6A, 6B
and 6C, exemplary flowcharts illustrate methods for combined ultrasound treatment in accordance with various exemplary embodiments of the present invention. With particular reference to an exemplary method illustrated in Fig. 6A, a user may use a transducer to deliver energy (step 601) to a region of interest. As used herein, the term user may include a person, employee, doctor, nurse, and/or technician, utilizing any hardware and/or software of other control systems. By delivering energy, the transducer may be driven at a selected frequency, a phased array may be driven with certain temporal and/or spatial distributions, a transducer may be configured with one or more transduction elements to provide focused, defocused and/or planar energy, and/or the transducer may be configured and/or
13 driven in any other ways hereinafter devised. Selection of the energy field for operation can be based on the type of effects and/or responses desired for an application.
The energy delivered in step 601 may provide, two or more energy effects (step 603) to a region of interest. An energy effect may be any effect described herein. The energy effects, in turn, may stimulate and/or initiate one or more responses (step 605) to the region of interest. The response(s) may be any response described herein.
Accordingly, two or more energy effects may provide a single response, two or more energy effects may provide two or more responses to provide treatment of a region of interest, and/or two or more energy effects may provide two or more responses that may be combined (step 650) into a single response to facilitate overall rejuvenation and treatment to the region of interest.
While an exemplary method for combined ultrasound treatment can be realized in the preceding series of steps 601, 603, 605 and 650, an exemplary method for combined ultrasound treatment may be achieved through any of the steps being performed in any order. For example, with reference to an exemplary flowchart illustrated in Fig. 6B, a user may use a transducer to deliver energy (step 611) to a region of interest. The energy may be delivered through a phase array with certain temporal and/or spatial distributions, through a transducer configured with one or more transduction elements to provide focused, defocused and/or planar energy, and/or through a transducer configured and/or driven any other way described herein and/or hereinafter devised. The energy may be used to provide a first energy effect (step 613) to a region of interest. The first effect may be any effect described herein. The first effect, in turn, may initiate and/or stimulate a first response (step 615) to a region of interest. The first response may be any response described herein.
The transducer may also be configured to deliver energy again (step 617) to provide a second energy effect (step 619) to the same and/or different region of interest, initiating and/or stimulating a second response or combining with the first energy effect to provide the first response (step 621) to the same and/or different region of interest. By delivering energy for a second time, the transducer may be driven at the same frequency as in step 611 and/or at a different frequency than that of step 611. The second effect and second response may be any effect and response described herein. The first and second effects and/or responses may occur instantaneously and/or may develop over a longer duration period, such as, for example, one week, with one or more delay periods in
14 between. In the event that the first and secend effect produce two or more responses, the two or more of the responses may also be combined (step 650) to facilitate overall rejuvenation and treatment to the region of interest.
Another example of an exemplary method for combined ultrasound treatment is illustrated in Fig. 6C. A user may use a transducer to deliver one or more energy fields (step 631) to a region of interest. By delivering energy, the transducer may be driven at a certain frequency, a phase array may be driven with certain temporal and/or spatial distributions, a transducer may be configured with one or more transduction elements to provide focused, defocused and/or planar energy, and/or the transducer may be configured and/or driven any other ways hereinafter devised. The energy fields may be delivered simultaneously, the energy may be delivered at delayed and/or overlapping times, and/or the energy may be delayed at different times altogether.
Each energy field delivered may provide one or more energy effects (step 633) to a region of interest. The energy effects may be any effects described herein.
Each energy effect may initiate and/or stimulate and provide and/or combine one or more responses (step 635) to the same and/or a different region of interest. The responses may be any response described herein. The energy effects and/or responses may occur instantaneously, simultaneously, and/or may develop over a longer duration period, such as, for example, one week. Two or more of the responses may be combined (step 650) to facilitate overall rejuvenation and treatment to the region of interest. While the present invention describes a method for combined ultrasound treatment in the preceding series of steps, the method of the present invention may be achieved through any of the steps being performed in any order.
As discussed above, an exemplary transducer embodiment for providing a combined ultrasound treatment can be configured to provide imaging/therapy and/or tissue parameter monitoring within a single transducer. For example, with reference to Figure 7A, an imaging subsystem 710 can be interfaced to an exemplary imaging/therapy and/or tissue parameter monitoring acoustic transducer assembly 700. The imaging subsystem connected to the acoustic transducer assembly 700 via a cable 760 includes a beam forming control unit. The unit is operated so that the acoustic transducer assembly 700 scans the region-of-interest, including the treatment region, in the target tissue 780 with the acoustic waves. The returning acoustic signal is received by the acoustic transducer assembly 700, and then sent to the imaging subsystem 710 to generate ultrasonic images of the treatment region. The thus generated image is displayed on a video display terminal 750 to assist the user in appropriately positioning the acoustic transducer assembly 700 with respect to the treatment region in the target tissue 780 prior to actually commencing the therapeutic treatment process.
With reference to Figure 14B, a therapy subsystem (a therapeutic heating system) 720, which is interfaced to the exemplary combined imaging/therapy acoustic transducer assembly 700, is connected to the combined imaging/therapy acoustic transducer assembly 700 via a cable 760 includes power RF or other types of drivers which are interfaced to the linear array of the acoustic transducer assembly 700. The power RF drivers are controlled in-time so that the acoustic transducer assembly 700 transmits, steers, and/or focuses the acoustic waves to the region-of-interest including the treatment region in the target tissue 780. Heating power and heating time as well as transducer anodization are all controlled during the therapeutic treatment process to achieve the proper heating pattern and therapeutic dosage. =
Tissue parameter monitoring, such as temperatures, can be monitored in a manner calculated to avoid tissue motion artifacts. For example, in the case where a localized region is heated, the heated region is interrogated with a pulse echo signal substantially immediately thereafter. In such a case the echo from the heated region will be changed in time and amplitude. For example, the acoustic attenuation in tissue approximately doubles from 50 C to 70 C. The region is measured immediately before and after heating and thus, = tissue motion artifacts are avoided, as well as any acoustic propagation effects.
In the case where only a small region is treated at a time, an isothermal region about the hot spot is engendered. Therefore, the time-of-flight and the amplitude of wave incident on the heated region is the same before and after the therapeutic energy is delivered. Thus, the amplitude change and time change measured after therapy will be due substantially to the tissue treated.
With reference to Figure 7C, where a combined imaging/therapy transducer assembly 1300 is used to heat a small region 780, with a temperature monitoring subsystem 730 is connected to display 750. Temperature monitoring subsystem 730 is also connected to transducer assembly 700, such as by a suitable cable 760. In accordance with this example, the whole volume is scanned, and by sweeping the pulse echo the effective thermal dose (time/temperature history) (e.g. recrossed volume) can be determined. The term thermal dose relates to the temperature and,time of duration integral function by which, for example, a determination of necrosity can be made.
The present invention has been described above with reference to various exemplary embodiments. However, those skilled in the art will recognize that changes and modifications may be made to the exemplary embodiments without departing from the scope of the present invention. For example, the various operational steps, as well as the components for carrying out the operational steps, may be implemented in alternate ways.
depending upon the particular application or in consideration of any number of cost functions associated with the operation of the system, e.g., various of the steps may be deleted, modified, or combined with other steps. Further, it should be noted that while the method and system for combined ultrasound treatment with a transducer is described above is suitable for use by a medical practitioner proximate the patient, the system can also be accessed remotely, i.e., the medical practitioner can view through a remote display having imaging information transmitted in various manners of communication, such as by satellite/wireless or by wired connections such as IP or digital cable networks and the like, and can direct a local practitioner as to the suitably placement for the transducer. These and other changes or modifications are intended to be included within the scope of the present invention, as set forth in the following claims.

Claims (23)

1. An ultrasound system configured for providing treatment comprising:
a single broadband ultrasound transducer configured to be excited at least two or more frequencies, said single broadband transducer excited at a first frequency providing a first ultrasound energy field into a region of interest and excited at a second frequency providing a second ultrasound energy field into said region of interest, wherein said first frequency and said first ultrasound energy field are different from said second frequency and said second ultrasound energy field, and said first ultrasound energy field creates an ablative or a hemostatic effect on tissue in said region of interest and said second ultrasound energy field creates at least one effect consisting of acoustic streaming, cavitational, hydrodynamic, diathermic, ablative, and resonance induced, on said tissue in said region of interest;
a control system that is connected to said single broadband ultrasound transducer and configured to operatively control said first frequency independently of said second frequency;
and wherein said first energy field and said second energy field are configured to induce and/or stimulate at least one biological response in said region of interest and said control system is configured to provide said second energy field after a delay period after said first energy field or to simultaneously provide said first energy field and said second energy field; wherein a combination of said ablative or hemostatic effect and said at least one effect consisting of acoustic streaming, cavitational, hydrodynamic, diathermic, ablative, and resonance induced, are configured to induce or stimulate at least one biological response to produce a higher efficacy and faster rejuvenation of skin without causing chronic injury to said tissue in said region of interest.
2. The ultrasound treatment system according to claim 1, wherein said region of interest comprises at least one of a superficial, subcutaneous, and an inner region of a patient.
3. The ultrasound treatment system according to claim 1, wherein said single broadband ultrasound transducer comprises a variable-thickness transduction element.
4. The ultrasound treatment system according to claim 1, wherein said first frequency comprises a transduction element configured for low frequency treatment and said second frequency comprises a transduction element configured for high-frequency treatment.
5. The ultrasound treatment system according to claim 1, wherein said single broadband ultrasound transducer comprises an array configured for providing a focused treatment.
6. The ultrasound treatment system according to claim 1, wherein said ultrasound transducer comprises an electronic focusing array.
7. The ultrasound treatment system according to claim 1, wherein said single broadband ultrasound transducer comprises an annular array.
8. An ultrasound treatment system according to claim 1, wherein said at least two or more ultrasound energy field are configured to facilitate at least two biological responses in said region of interest.
9. An ultrasound system according to claim 1, further comprising a coupling system configured for acoustic coupling between said single ultrasound transducer and said region of interest.
10. An ultrasound system according to claim 9, wherein said coupling system is configured for controlled cooling of an interface surface proximate to said region of interest to facilitate control of thermal energy effects of said ultrasound treatment system.
11. An ultrasound system according to claim 1, wherein said ultrasound treatment system is configured for providing at least one of therapy, imaging and tissue parameter monitoring.
12. An ultrasound system according to claim 1, wherein said ultrasound treatment system is configured for providing combined therapy and imaging treatment.
13. A system for providing non-invasive ultrasound treatment to a patient, said system comprising:

a transducer configured to emit ultrasound energy field to provide a first effect on tissue in a region of interest, wherein said first effect is at least one of acoustic streaming, cavitational, hydrodynamic, ablative, hemostatic, diathermic, and resonance induced and wherein said first effect initiates and/or stimulates a first biological response in said region of interest, wherein said first biological response in said region of interest comprises at least one of a hemostasis, subsequent revascularization/angiogenesis, coagulative necrosis, growth of interconnective tissue, tissue reformation, ablation of existing tissue, collagen reformation, enhanced delivery and activation of medicants, stimulation of protein synthesis and increased cell permeability response; and said transducer configured to emit ultrasound energy to provide a second effect on tissue in a region of interest, wherein said second effect is at least one of acoustic streaming, cavitational, hydrodynamic, ablative, hemostatic, diathermic, and resonance induced and wherein said second effect initiates and/or stimulates a second biological response in said region of interest, wherein said second biological response in said region of interest comprises at least one of hemostasis, subsequent revascularization/angiogenesis, growth of interconnective tissue, tissue reformation, ablation of existing tissue, collagen reformation, enhanced delivery and activation of medicants, stimulation of protein synthesis and increased cell permeability response, wherein said second effect is distinct from and independent of said first effect and occurs after one or more delay periods after said first effect.
14. The system according to claim 13, further comprising a control system configured to control said transducer to emit said ultrasound energy.
15. The system according to claim 14, wherein said first response and said second biological response produce an overall response in said region of interest.
16. The system according to claim 13, wherein a combination of said first effect on said tissue in said region of interest and said second effect on said tissue in said region of interest, are configured to induce or stimulate said first biological response and said second biological response in said region of interest to produce a higher efficacy and faster rejuvenation of skin without causing chronic injury to said tissue in said region of interest.
17. The system according to claim 13, wherein said second response is the same as or different from said first response.
18. A system for providing non-invasive ultrasound treatment to a patient, said system comprising:
means for providing one of a first planar, defocused, or focused-ultrasound energy beam at a first frequency to a region of interest to produce a first-effect on tissue in said region of interest to initiate and/or stimulate a corresponding first biological response in said region of interest; and means for providing one of a second planar, defocused, or focused ultrasound energy beam at a second frequency to said region of interest to produce a second effect on tissue in said region of interest to initiate and/or stimulate a corresponding second biological response in said region of interest; wherein said first planar, defocused, or focused ultrasound energy beam and said second planar, defocused, or focused ultrasound energy beam are capable of creating said first response and said second response, wherein said second effect on said tissue occurs after one or more delay periods after said first effect on said tissue;
wherein said first effect on said tissue is one of acoustic streaming, cavitational, hydrodynamic, ablative, hemostatic, diathermic, and resonance induced effect on tissue in said region of interest; and wherein said second effect on said tissue is one of acoustic streaming, cavitational, hydrodynamic, ablative, hemostatic, diathermic, and resonance induced effect on tissue in said region of interest, and wherein said second effect is different from said first effect.
19. The system according to claim 18, wherein said first biological response is one of a hemostasis, subsequent revascularization/angiogenesis, growth of interconnective tissue, tissue reformation, ablation of existing tissue, collagen reformation, enhanced delivery and activation of medicants, stimulation of protein synthesis and increased cell permeability response.
20. The system according to claim 18, wherein said second biological response is one of a hemostasis, subsequent revascularization/angiogenesis, growth of interconnective tissue, tissue reformation, ablation of existing tissue, collagen reformation, enhanced delivery and activation of medicants, stimulation of protein synthesis and increased cell permeability response, and wherein said second biological response is the same as or different from said first biological response.
21 21. The ultrasound system according to claim 1, wherein said single broadband ultrasound transducer further comprises a backing layer and a matching layer attached to said transducer.
22. The system according to claim 14, wherein said ultrasound energy is emitted at said first frequency range and amplitude and also emitted at a harmonic frequency range.
23. The system according to claim 18, wherein a combination said first effect and said second effect on said tissue are configured to induce or stimulate said first biological response and said second biological response in said region of interest to produce a higher efficacy and faster rejuvenation of skin without causing chronic injury to said tissue in said region of interest.
CA2860065A 2004-09-24 2005-09-22 Method and system for combined ultrasound treatment Active CA2860065C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/950,112 US7530958B2 (en) 2004-09-24 2004-09-24 Method and system for combined ultrasound treatment
US10/950,112 2004-09-24
CA2580561A CA2580561C (en) 2004-09-24 2005-09-22 Method and system for combined ultrasound treatment

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA2580561A Division CA2580561C (en) 2004-09-24 2005-09-22 Method and system for combined ultrasound treatment

Publications (2)

Publication Number Publication Date
CA2860065A1 true CA2860065A1 (en) 2006-04-06
CA2860065C CA2860065C (en) 2017-11-07

Family

ID=35447375

Family Applications (2)

Application Number Title Priority Date Filing Date
CA2860065A Active CA2860065C (en) 2004-09-24 2005-09-22 Method and system for combined ultrasound treatment
CA2580561A Active CA2580561C (en) 2004-09-24 2005-09-22 Method and system for combined ultrasound treatment

Family Applications After (1)

Application Number Title Priority Date Filing Date
CA2580561A Active CA2580561C (en) 2004-09-24 2005-09-22 Method and system for combined ultrasound treatment

Country Status (9)

Country Link
US (2) US7530958B2 (en)
EP (2) EP1809377B1 (en)
JP (4) JP2008514294A (en)
KR (2) KR101269918B1 (en)
CA (2) CA2860065C (en)
ES (1) ES2629301T3 (en)
HK (1) HK1248630A1 (en)
IL (1) IL181892A (en)
WO (1) WO2006036870A1 (en)

Families Citing this family (144)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6104959A (en) 1997-07-31 2000-08-15 Microwave Medical Corp. Method and apparatus for treating subcutaneous histological features
US6050943A (en) 1997-10-14 2000-04-18 Guided Therapy Systems, Inc. Imaging, therapy, and temperature monitoring ultrasonic system
AU2619301A (en) 1999-10-25 2001-06-06 Therus Corporation Use of focused ultrasound for vascular sealing
US6626855B1 (en) 1999-11-26 2003-09-30 Therus Corpoation Controlled high efficiency lesion formation using high intensity ultrasound
US7914453B2 (en) 2000-12-28 2011-03-29 Ardent Sound, Inc. Visual imaging system for ultrasonic probe
US20030092988A1 (en) 2001-05-29 2003-05-15 Makin Inder Raj S. Staging medical treatment using ultrasound
US7846096B2 (en) 2001-05-29 2010-12-07 Ethicon Endo-Surgery, Inc. Method for monitoring of medical treatment using pulse-echo ultrasound
US20030069569A1 (en) 2001-08-29 2003-04-10 Burdette Everette C. Ultrasound device for treatment of intervertebral disc tissue
US8235909B2 (en) 2004-05-12 2012-08-07 Guided Therapy Systems, L.L.C. Method and system for controlled scanning, imaging and/or therapy
US7806839B2 (en) 2004-06-14 2010-10-05 Ethicon Endo-Surgery, Inc. System and method for ultrasound therapy using grating lobes
US7824348B2 (en) 2004-09-16 2010-11-02 Guided Therapy Systems, L.L.C. System and method for variable depth ultrasound treatment
US7393325B2 (en) 2004-09-16 2008-07-01 Guided Therapy Systems, L.L.C. Method and system for ultrasound treatment with a multi-directional transducer
US9011336B2 (en) 2004-09-16 2015-04-21 Guided Therapy Systems, Llc Method and system for combined energy therapy profile
US8750983B2 (en) 2004-09-20 2014-06-10 P Tech, Llc Therapeutic system
US10864385B2 (en) 2004-09-24 2020-12-15 Guided Therapy Systems, Llc Rejuvenating skin by heating tissue for cosmetic treatment of the face and body
US8535228B2 (en) 2004-10-06 2013-09-17 Guided Therapy Systems, Llc Method and system for noninvasive face lifts and deep tissue tightening
US8444562B2 (en) 2004-10-06 2013-05-21 Guided Therapy Systems, Llc System and method for treating muscle, tendon, ligament and cartilage tissue
US8133180B2 (en) 2004-10-06 2012-03-13 Guided Therapy Systems, L.L.C. Method and system for treating cellulite
US9694212B2 (en) 2004-10-06 2017-07-04 Guided Therapy Systems, Llc Method and system for ultrasound treatment of skin
US7758524B2 (en) 2004-10-06 2010-07-20 Guided Therapy Systems, L.L.C. Method and system for ultra-high frequency ultrasound treatment
US11235179B2 (en) 2004-10-06 2022-02-01 Guided Therapy Systems, Llc Energy based skin gland treatment
US8690778B2 (en) 2004-10-06 2014-04-08 Guided Therapy Systems, Llc Energy-based tissue tightening
EP1879502A2 (en) 2004-10-06 2008-01-23 Guided Therapy Systems, L.L.C. Method and system for cosmetic enhancement
US7530356B2 (en) * 2004-10-06 2009-05-12 Guided Therapy Systems, Inc. Method and system for noninvasive mastopexy
US8663112B2 (en) 2004-10-06 2014-03-04 Guided Therapy Systems, Llc Methods and systems for fat reduction and/or cellulite treatment
KR101605527B1 (en) 2004-10-06 2016-03-22 가이디드 테라피 시스템스, 엘.엘.씨. Ultrasound treatment system
US20060111744A1 (en) 2004-10-13 2006-05-25 Guided Therapy Systems, L.L.C. Method and system for treatment of sweat glands
US9827449B2 (en) 2004-10-06 2017-11-28 Guided Therapy Systems, L.L.C. Systems for treating skin laxity
US11883688B2 (en) 2004-10-06 2024-01-30 Guided Therapy Systems, Llc Energy based fat reduction
US11724133B2 (en) 2004-10-07 2023-08-15 Guided Therapy Systems, Llc Ultrasound probe for treatment of skin
US11207548B2 (en) 2004-10-07 2021-12-28 Guided Therapy Systems, L.L.C. Ultrasound probe for treating skin laxity
US20060224090A1 (en) * 2005-03-29 2006-10-05 Isaac Ostrovsky Apparatus and method for stiffening tissue
JP4695188B2 (en) 2005-04-25 2011-06-08 アーデント サウンド, インコーポレイテッド Method and apparatus for improving the safety of computer peripherals
US20070194658A1 (en) * 2005-07-13 2007-08-23 Jimin Zhang Systems and methods for performing acoustic hemostasis of deep bleeding trauma in limbs
US7955262B2 (en) * 2005-07-26 2011-06-07 Syneron Medical Ltd. Method and apparatus for treatment of skin using RF and ultrasound energies
WO2007019365A2 (en) * 2005-08-03 2007-02-15 Massachusetts Eye & Ear Infirmary Targeted muscle ablation for reducing signs of aging
US20070213616A1 (en) 2005-10-20 2007-09-13 Thomas Anderson Systems and methods for arteriotomy localization
US8133191B2 (en) * 2006-02-16 2012-03-13 Syneron Medical Ltd. Method and apparatus for treatment of adipose tissue
US9566454B2 (en) * 2006-09-18 2017-02-14 Guided Therapy Systems, Llc Method and sysem for non-ablative acne treatment and prevention
US9241683B2 (en) 2006-10-04 2016-01-26 Ardent Sound Inc. Ultrasound system and method for imaging and/or measuring displacement of moving tissue and fluid
US8038622B2 (en) * 2007-08-03 2011-10-18 Innoscion, Llc Wired and wireless remotely controlled ultrasonic transducer and imaging apparatus
US10183183B2 (en) * 2007-04-13 2019-01-22 Acoustic Medsystems, Inc. Acoustic applicators for controlled thermal modification of tissue
US9149331B2 (en) 2007-04-19 2015-10-06 Miramar Labs, Inc. Methods and apparatus for reducing sweat production
JP2010524589A (en) 2007-04-19 2010-07-22 ザ ファウンドリー, インコーポレイテッド Method, apparatus and system for non-invasive delivery of microwave therapy
US20100211059A1 (en) 2007-04-19 2010-08-19 Deem Mark E Systems and methods for creating an effect using microwave energy to specified tissue
CN101711134B (en) 2007-04-19 2016-08-17 米勒玛尔实验室公司 Tissue is applied the system of microwave energy and in organized layer, produces the system of tissue effect
US9241763B2 (en) 2007-04-19 2016-01-26 Miramar Labs, Inc. Systems, apparatus, methods and procedures for the noninvasive treatment of tissue using microwave energy
EP2152351B1 (en) 2007-05-07 2016-09-21 Guided Therapy Systems, L.L.C. Methods and systems for modulating medicants using acoustic energy
EP2152367B1 (en) * 2007-05-07 2018-07-11 Guided Therapy Systems, L.L.C. System for combined energy therapy profile
US20150174388A1 (en) * 2007-05-07 2015-06-25 Guided Therapy Systems, Llc Methods and Systems for Ultrasound Assisted Delivery of a Medicant to Tissue
ES2699477T3 (en) 2007-05-07 2019-02-11 Guided Therapy Systems Llc Methods and systems for coupling and focusing acoustic energy using a coupling member
WO2009021535A1 (en) * 2007-08-14 2009-02-19 Campus Micro Technologies Gmbh Medical devices, systems and methods for blood pressure regulation
US20090062724A1 (en) * 2007-08-31 2009-03-05 Rixen Chen System and apparatus for sonodynamic therapy
ES2471971T3 (en) 2007-12-12 2014-06-27 Miramar Labs, Inc. System and apparatus for non-invasive treatment of tissue using microwave energy
AU2008335715B2 (en) 2007-12-12 2014-01-23 Miradry, Inc. Systems, apparatus, methods and procedures for the noninvasive treatment of tissue using microwave energy
US20090254008A1 (en) * 2008-01-29 2009-10-08 Shields Jr Donald J Systems, devices, and methods to concurrently deliver ultrasound waves having thermal and non-thermal effects
US7943187B2 (en) * 2008-05-23 2011-05-17 Bakr Rabie Paeoniflorin preparations and uses thereof for fat reduction
JP5229473B2 (en) * 2008-06-04 2013-07-03 財団法人ヒューマンサイエンス振興財団 Ultrasound medical equipment
KR102147455B1 (en) 2008-06-06 2020-08-24 얼테라, 인크 Ultrasound treatment system
AU2014203177B2 (en) * 2008-06-06 2015-07-16 Ulthera, Inc. A system and method for cosmetic treatment and imaging
US20090318852A1 (en) * 2008-06-18 2009-12-24 Jenu Biosciences, Inc. Ultrasound based cosmetic therapy method and apparatus
CN105126262B (en) 2008-07-14 2019-03-22 代理并代表亚利桑那州立大学的亚利桑那董事会 Method and apparatus using ultrasound for adjusting cell activity
US8585618B2 (en) * 2008-12-22 2013-11-19 Cutera, Inc. Broad-area irradiation of small near-field targets using ultrasound
US20100286519A1 (en) * 2009-05-11 2010-11-11 General Electric Company Ultrasound system and method to automatically identify and treat adipose tissue
US20100286520A1 (en) * 2009-05-11 2010-11-11 General Electric Company Ultrasound system and method to determine mechanical properties of a target region
US20100286518A1 (en) * 2009-05-11 2010-11-11 General Electric Company Ultrasound system and method to deliver therapy based on user defined treatment spaces
US20110092880A1 (en) 2009-10-12 2011-04-21 Michael Gertner Energetic modulation of nerves
US20110118600A1 (en) 2009-11-16 2011-05-19 Michael Gertner External Autonomic Modulation
US8986231B2 (en) 2009-10-12 2015-03-24 Kona Medical, Inc. Energetic modulation of nerves
US8986211B2 (en) 2009-10-12 2015-03-24 Kona Medical, Inc. Energetic modulation of nerves
US8469904B2 (en) 2009-10-12 2013-06-25 Kona Medical, Inc. Energetic modulation of nerves
US9119951B2 (en) 2009-10-12 2015-09-01 Kona Medical, Inc. Energetic modulation of nerves
US8517962B2 (en) 2009-10-12 2013-08-27 Kona Medical, Inc. Energetic modulation of nerves
US20160059044A1 (en) 2009-10-12 2016-03-03 Kona Medical, Inc. Energy delivery to intraparenchymal regions of the kidney to treat hypertension
US8295912B2 (en) 2009-10-12 2012-10-23 Kona Medical, Inc. Method and system to inhibit a function of a nerve traveling with an artery
US9174065B2 (en) * 2009-10-12 2015-11-03 Kona Medical, Inc. Energetic modulation of nerves
US8597192B2 (en) 2009-10-30 2013-12-03 Warsaw Orthopedic, Inc. Ultrasonic devices and methods to diagnose pain generators
US8715186B2 (en) 2009-11-24 2014-05-06 Guided Therapy Systems, Llc Methods and systems for generating thermal bubbles for improved ultrasound imaging and therapy
US20110144545A1 (en) * 2009-12-15 2011-06-16 General Electric Company Methods And System For Delivering Treatment To A Region Of Interest Using Ultrasound
WO2011107927A1 (en) * 2010-03-01 2011-09-09 Yoni Iger Method and apparatus for the removal of non desired biological components from external surfaces of tissues
WO2011107885A2 (en) * 2010-03-01 2011-09-09 Yoni Iger System, device and methods of tissue treatment for achieving tissue specific effects
US9504446B2 (en) 2010-08-02 2016-11-29 Guided Therapy Systems, Llc Systems and methods for coupling an ultrasound source to tissue
KR101939725B1 (en) 2010-08-02 2019-01-17 가이디드 테라피 시스템스, 엘.엘.씨. System and Method for Ultrasound Treatment
US8857438B2 (en) 2010-11-08 2014-10-14 Ulthera, Inc. Devices and methods for acoustic shielding
CN103260536B (en) 2010-12-09 2016-06-08 日立阿洛卡医疗株式会社 Apparatus for ultrasonic therapeutic treatment and control method thereof
KR101644011B1 (en) * 2011-02-01 2016-08-01 주식회사 하이로닉 High Intensity Focused Ultrasonic Medical Instrument with Dual Transducers
KR102068724B1 (en) 2011-07-10 2020-01-21 가이디드 테라피 시스템스, 엘.엘.씨. Systems and methods for improving an outside appearance of skin using ultrasound as an energy source
EP2731675B1 (en) 2011-07-11 2023-05-03 Guided Therapy Systems, L.L.C. Systems and methods for coupling an ultrasound source to tissue
US9314301B2 (en) 2011-08-01 2016-04-19 Miramar Labs, Inc. Applicator and tissue interface module for dermatological device
EP2768396A2 (en) 2011-10-17 2014-08-27 Butterfly Network Inc. Transmissive imaging and related apparatus and methods
EP2768385B1 (en) 2011-10-21 2021-03-31 Cerevast Medical, Inc. System for direct communication
US9263663B2 (en) 2012-04-13 2016-02-16 Ardent Sound, Inc. Method of making thick film transducer arrays
US10517569B2 (en) 2012-05-09 2019-12-31 The Regents Of The University Of Michigan Linear magnetic drive transducer for ultrasound imaging
US20150209551A1 (en) 2012-08-15 2015-07-30 Everette C. Burdette Mri compatible ablation catheter system incorporating directional high-intensity ultrasound for treatment
WO2014031760A1 (en) * 2012-08-21 2014-02-27 Regents Of The University Of Minnesota System for the treatment of collagen structural abnormalities
WO2014036170A1 (en) 2012-08-29 2014-03-06 Thync, Inc. Systems and devices for coupling ultrasound energy to a body
US9510802B2 (en) 2012-09-21 2016-12-06 Guided Therapy Systems, Llc Reflective ultrasound technology for dermatological treatments
CN104027893B (en) 2013-03-08 2021-08-31 奥赛拉公司 Apparatus and method for multi-focal ultrasound therapy
WO2014146022A2 (en) 2013-03-15 2014-09-18 Guided Therapy Systems Llc Ultrasound treatment device and methods of use
US9667889B2 (en) 2013-04-03 2017-05-30 Butterfly Network, Inc. Portable electronic devices with integrated imaging capabilities
KR101501479B1 (en) * 2013-05-09 2015-03-11 알피니언메디칼시스템 주식회사 Method for Optimizing Ultrasound, Ultrasound Medical Apparatus Therefor
WO2015013502A2 (en) 2013-07-24 2015-01-29 Miramar Labs, Inc. Apparatus and methods for the treatment of tissue using microwave energy
KR101896565B1 (en) 2014-07-26 2018-09-07 주식회사 하이로닉 High intensity focused ultrasound operating apparatus
PL3017845T3 (en) 2014-03-18 2022-01-31 Hironic Co., Ltd. High-intensity focused ultrasound operation device
EP3131630B1 (en) 2014-04-18 2023-11-29 Ulthera, Inc. Band transducer ultrasound therapy
KR101811351B1 (en) 2014-08-11 2017-12-26 주식회사 하이로닉 High intensity focused ultrasound operating apparatus
US10925579B2 (en) 2014-11-05 2021-02-23 Otsuka Medical Devices Co., Ltd. Systems and methods for real-time tracking of a target tissue using imaging before and during therapy delivery
KR101742957B1 (en) 2014-11-26 2017-06-02 주식회사 아띠베뷰티 Ultrasound apparatus
KR101750015B1 (en) 2014-11-26 2017-06-22 주식회사 아띠베뷰티 Ultrasound apparatus
JP2018500075A (en) 2014-11-26 2018-01-11 アティーブ ビューティー カンパニー リミテッドATTIBE Beauty CO. LTD. Ultrasonic generator and treatment method using the same
KR101822539B1 (en) 2015-02-25 2018-03-08 주식회사 아띠베뷰티 Ultrasound apparatus
KR102428353B1 (en) 2014-12-29 2022-08-02 주식회사 하이로닉 High intensity focused ultrasound operating apparatus and operating method thereof
KR101732649B1 (en) 2015-06-01 2017-05-04 주식회사 하이로닉 High intensity focused ultrasound operating apparatus
KR101713318B1 (en) 2015-06-09 2017-03-09 주식회사 하이로닉 High intensity focused ultrasound operating apparatus
KR101886673B1 (en) 2014-12-19 2018-08-08 주식회사 하이로닉 High intensity focused ultrasound operating apparatus and operating method thereof
US10252044B2 (en) * 2015-02-27 2019-04-09 Robert T. Bock Consultancy, Llc Ultrasonic method and device for cosmetic applications
WO2016144931A1 (en) 2015-03-09 2016-09-15 The Research Foundation For The State University Of New York Systems and methods for promoting cellular activities for tissue maintenance, repair, and regeneration
KR102447731B1 (en) 2015-05-28 2022-09-27 주식회사 하이로닉 High intensity focused ultrasound device
KR20160139518A (en) 2015-05-28 2016-12-07 주식회사 하이로닉 Aesthetic treatment method for using high intensity focused ultrasound
KR20160139517A (en) 2015-05-28 2016-12-07 주식회사 하이로닉 Ultrasoud catridge for high intensity focused ultrasound device
KR101676012B1 (en) 2015-07-30 2016-11-15 주식회사 아띠베뷰티 Operating apparatus for skin treatment
KR102581952B1 (en) 2015-09-02 2023-09-22 주식회사 하이로닉 Focused ultrasound operating apparatus
US11241334B2 (en) * 2015-09-24 2022-02-08 Visionage Therapies, Llc Sonic and ultrasonic contact lens apparatus
KR102591570B1 (en) 2015-12-22 2023-10-19 주식회사 하이로닉 Intensity focused ultrasound operating apparatus
KR102591566B1 (en) 2015-12-22 2023-10-19 주식회사 하이로닉 Intensity focused ultrasound operating apparatus
IL259944B (en) 2016-01-18 2022-07-01 Ulthera Inc Compact ultrasound device having annular ultrasound array peripherally electrically connected to flexible printed circuit board and method of assembly thereof
KR20160075388A (en) 2016-05-02 2016-06-29 주식회사 하이로닉 High intensity focused ultrasound apparatus and operating method thereof
BR112018072101B1 (en) 2016-08-16 2024-01-02 Ulthera, Inc SYSTEMS AND METHODS FOR COSMETIC SKIN TREATMENT WITH ULTRASOUND
WO2018071908A1 (en) 2016-10-16 2018-04-19 Vibrato Medical, Inc. Extracorporeal therapeutic ultrasound for promoting angiogenesis
KR102184524B1 (en) 2016-11-08 2020-11-30 주식회사 아띠베뷰티 Operating apparatus for skin treatment
KR20180087488A (en) 2017-01-23 2018-08-02 주식회사 아띠베뷰티 Ultrasound operating apparatus and system having the same
KR102151264B1 (en) 2017-01-31 2020-09-02 주식회사 하이로닉 High intensity focused ultrasound operating apparatus
KR102168246B1 (en) 2017-02-28 2020-10-20 주식회사 하이로닉 High intensity focused ultrasound operating apparatus
KR101987164B1 (en) 2017-03-23 2019-09-30 주식회사 하이로닉 Intensity focused ultrasound operating apparatus
KR102105146B1 (en) 2017-04-07 2020-05-29 주식회사 하이로닉 Operating apparatus for skin treatment
KR101976479B1 (en) 2017-04-21 2019-05-10 주식회사 하이로닉 Ultrasoud catridge for high intensity focused ultrasound device
MY179669A (en) 2017-11-01 2020-11-11 Fusion Group Holdings Co Ltd Method of preparing combustible oil
WO2019135160A2 (en) * 2018-01-05 2019-07-11 Insightec, Ltd. Multi-frequency ultrasound transducers
EP3764908B1 (en) * 2018-03-16 2023-01-11 Institut National De La Sante Et De La Recherche Medicale - Inserm Method and apparatus for determining local acoustic field intensity within a soft solid
KR102149062B1 (en) 2018-12-17 2020-08-28 주식회사 하이로닉 Intensity focused ultrasound operating apparatus
US20220226672A1 (en) * 2019-06-10 2022-07-21 National Health Research Institutes Focused ultrasound device and method for dermatological treatment
KR20190088948A (en) 2019-07-19 2019-07-29 주식회사 아띠베뷰티 Ultrasound operating apparatus and system having the same
WO2022197662A2 (en) * 2021-03-15 2022-09-22 Guided Therapy Systems, Llc Method for mid-intensity, non-ablative acoustic treatment of injured tissue
KR20230055481A (en) 2021-10-19 2023-04-26 주식회사 에이디씨 High intensity focused ultrasound operating apparatus and driving method thereof

Family Cites Families (211)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2427348A (en) * 1941-08-19 1947-09-16 Bell Telephone Labor Inc Piezoelectric vibrator
FR2190364B1 (en) * 1972-07-04 1975-06-13 Patru Marcel
FR2214378A5 (en) * 1973-01-16 1974-08-09 Commissariat Energie Atomique
FR2254030B1 (en) * 1973-12-10 1977-08-19 Philips Massiot Mat Medic
US3965455A (en) * 1974-04-25 1976-06-22 The United States Of America As Represented By The Secretary Of The Navy Focused arc beam transducer-reflector
US4059098A (en) * 1975-07-21 1977-11-22 Stanford Research Institute Flexible ultrasound coupling system
AT353506B (en) * 1976-10-19 1979-11-26 List Hans PIEZOELECTRIC RESONATOR
JPS5353393A (en) * 1976-10-25 1978-05-15 Matsushita Electric Ind Co Ltd Ultrasonic probe
US4213344A (en) * 1978-10-16 1980-07-22 Krautkramer-Branson, Incorporated Method and apparatus for providing dynamic focussing and beam steering in an ultrasonic apparatus
US4211948A (en) * 1978-11-08 1980-07-08 General Electric Company Front surface matched piezoelectric ultrasonic transducer array with wide field of view
US4211949A (en) * 1978-11-08 1980-07-08 General Electric Company Wear plate for piezoelectric ultrasonic transducer arrays
US4276491A (en) * 1979-10-02 1981-06-30 Ausonics Pty. Limited Focusing piezoelectric ultrasonic medical diagnostic system
US4343301A (en) * 1979-10-04 1982-08-10 Robert Indech Subcutaneous neural stimulation or local tissue destruction
US4325381A (en) * 1979-11-21 1982-04-20 New York Institute Of Technology Ultrasonic scanning head with reduced geometrical distortion
JPS5686121A (en) * 1979-12-14 1981-07-13 Teijin Ltd Antitumor proten complex and its preparation
US4315514A (en) * 1980-05-08 1982-02-16 William Drewes Method and apparatus for selective cell destruction
US4381787A (en) * 1980-08-15 1983-05-03 Technicare Corporation Ultrasound imaging system combining static B-scan and real-time sector scanning capability
US4372296A (en) * 1980-11-26 1983-02-08 Fahim Mostafa S Treatment of acne and skin disorders and compositions therefor
US4484569A (en) * 1981-03-13 1984-11-27 Riverside Research Institute Ultrasonic diagnostic and therapeutic transducer assembly and method for using
US4381007A (en) 1981-04-30 1983-04-26 The United States Of America As Represented By The United States Department Of Energy Multipolar corneal-shaping electrode with flexible removable skirt
EP0068961A3 (en) * 1981-06-26 1983-02-02 Thomson-Csf Apparatus for the local heating of biological tissue
US4409839A (en) * 1981-07-01 1983-10-18 Siemens Ag Ultrasound camera
US4397314A (en) * 1981-08-03 1983-08-09 Clini-Therm Corporation Method and apparatus for controlling and optimizing the heating pattern for a hyperthermia system
US4441486A (en) * 1981-10-27 1984-04-10 Board Of Trustees Of Leland Stanford Jr. University Hyperthermia system
US4528979A (en) * 1982-03-18 1985-07-16 Kievsky Nauchno-Issledovatelsky Institut Otolaringologii Imeni Professora A.S. Kolomiiobenka Cryo-ultrasonic surgical instrument
US4431008A (en) * 1982-06-24 1984-02-14 Wanner James F Ultrasonic measurement system using a perturbing field, multiple sense beams and receivers
US4534221A (en) * 1982-09-27 1985-08-13 Technicare Corporation Ultrasonic diagnostic imaging systems for varying depths of field
US4507582A (en) * 1982-09-29 1985-03-26 New York Institute Of Technology Matching region for damped piezoelectric ultrasonic apparatus
US4452084A (en) * 1982-10-25 1984-06-05 Sri International Inherent delay line ultrasonic transducer and systems
EP0111386B1 (en) * 1982-10-26 1987-11-19 University Of Aberdeen Ultrasound hyperthermia unit
US4513749A (en) * 1982-11-18 1985-04-30 Board Of Trustees Of Leland Stanford University Three-dimensional temperature probe
US4527550A (en) * 1983-01-28 1985-07-09 The United States Of America As Represented By The Department Of Health And Human Services Helical coil for diathermy apparatus
JPH064074B2 (en) * 1983-02-14 1994-01-19 株式会社日立製作所 Ultrasonic diagnostic device and sound velocity measuring method using the same
FR2543437B1 (en) * 1983-03-30 1987-07-10 Duraffourd Alain COMPOSITION FOR REGENERATING COLLAGEN OF CONNECTIVE TISSUE OF THE SKIN AND METHOD FOR PREPARING SAME
US4900540A (en) * 1983-06-20 1990-02-13 Trustees Of The University Of Massachusetts Lipisomes containing gas for ultrasound detection
US4637256A (en) * 1983-06-23 1987-01-20 Matsushita Electric Industrial Co., Ltd. Ultrasonic probe having dual-motion transducer
FR2551611B1 (en) * 1983-08-31 1986-10-24 Labo Electronique Physique NOVEL ULTRASONIC TRANSDUCER STRUCTURE AND ULTRASONIC ECHOGRAPHY MEDIA EXAMINATION APPARATUS COMPRISING SUCH A STRUCTURE
US4601296A (en) * 1983-10-07 1986-07-22 Yeda Research And Development Co., Ltd. Hyperthermia apparatus
US5150711A (en) 1983-12-14 1992-09-29 Edap International, S.A. Ultra-high-speed extracorporeal ultrasound hyperthermia treatment device
US5143074A (en) * 1983-12-14 1992-09-01 Edap International Ultrasonic treatment device using a focussing and oscillating piezoelectric element
US4513750A (en) * 1984-02-22 1985-04-30 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Method for thermal monitoring subcutaneous tissue
US4567895A (en) * 1984-04-02 1986-02-04 Advanced Technology Laboratories, Inc. Fully wetted mechanical ultrasound scanhead
US4620546A (en) * 1984-06-30 1986-11-04 Kabushiki Kaisha Toshiba Ultrasound hyperthermia apparatus
DE3447440A1 (en) * 1984-12-27 1986-07-03 Siemens AG, 1000 Berlin und 8000 München SHOCK SHAFT PIPE FOR THE CRUSHING OF CONCRETE
DE3501808A1 (en) * 1985-01-21 1986-07-24 Siemens AG, 1000 Berlin und 8000 München ULTRASONIC CONVERTER
JPS61209643A (en) * 1985-03-15 1986-09-17 株式会社東芝 Ultrasonic diagnostic and medical treatment apparatus
DE3611669A1 (en) * 1985-04-10 1986-10-16 Hitachi Medical Corp., Tokio/Tokyo ULTRASONIC CONVERTER
JPH0678460B2 (en) * 1985-05-01 1994-10-05 株式会社バイオマテリアル・ユニバース Porous transparent polyvinyl alcohol gel
DE3650004T2 (en) * 1985-05-20 1995-02-23 Matsushita Electric Ind Co Ltd Ultrasound probe.
US4865042A (en) * 1985-08-16 1989-09-12 Hitachi, Ltd. Ultrasonic irradiation system
US5054310A (en) * 1985-09-13 1991-10-08 The California Province Of The Society Of Jesus Test object and method of measurement of an ultrasonic beam
US5304169A (en) 1985-09-27 1994-04-19 Laser Biotech, Inc. Method for collagen shrinkage
US4976709A (en) 1988-12-15 1990-12-11 Sand Bruce J Method for collagen treatment
EP0406915A1 (en) * 1985-12-13 1991-01-09 Matsushita Electric Industrial Co., Ltd. Ultrasonic diagnostic apparatus based on variations of acoustic characteristic
JPS6323126A (en) * 1986-02-13 1988-01-30 Bio Material Yunibaasu:Kk Soft contact lens and its production
JPS62249644A (en) * 1986-04-22 1987-10-30 日石三菱株式会社 Dummy living body structure
US4875487A (en) 1986-05-02 1989-10-24 Varian Associates, Inc. Compressional wave hyperthermia treating method and apparatus
US4807633A (en) * 1986-05-21 1989-02-28 Indianapolis Center For Advanced Research Non-invasive tissue thermometry system and method
US4803625A (en) * 1986-06-30 1989-02-07 Buddy Systems, Inc. Personal health monitor
US4867169A (en) * 1986-07-29 1989-09-19 Kaoru Machida Attachment attached to ultrasound probe for clinical application
US4801459A (en) * 1986-08-05 1989-01-31 Liburdy Robert P Technique for drug and chemical delivery
JPS63122923A (en) * 1986-11-13 1988-05-26 Agency Of Ind Science & Technol Ultrasonic thermometric apparatus
US4865041A (en) * 1987-02-04 1989-09-12 Siemens Aktiengesellschaft Lithotripter having an ultrasound locating system integrated therewith
JPS63220847A (en) * 1987-03-10 1988-09-14 松下電器産業株式会社 Ultrasonic probe
US5178135A (en) * 1987-04-16 1993-01-12 Olympus Optical Co., Ltd. Therapeutical apparatus of extracorporeal type
BG46024A1 (en) * 1987-05-19 1989-10-16 Min Na Narodnata Otbrana Method and device for treatment of bone patology
US4891043A (en) * 1987-05-28 1990-01-02 Board Of Trustees Of The University Of Illinois System for selective release of liposome encapsulated material via laser radiation
US4932414A (en) * 1987-11-02 1990-06-12 Cornell Research Foundation, Inc. System of therapeutic ultrasound and real-time ultrasonic scanning
US5040537A (en) * 1987-11-24 1991-08-20 Hitachi, Ltd. Method and apparatus for the measurement and medical treatment using an ultrasonic wave
US4917096A (en) 1987-11-25 1990-04-17 Laboratory Equipment, Corp. Portable ultrasonic probe
US4860732A (en) * 1987-11-25 1989-08-29 Olympus Optical Co., Ltd. Endoscope apparatus provided with endoscope insertion aid
US5163421A (en) 1988-01-22 1992-11-17 Angiosonics, Inc. In vivo ultrasonic system with angioplasty and ultrasonic contrast imaging
US5143063A (en) * 1988-02-09 1992-09-01 Fellner Donald G Method of removing adipose tissue from the body
US5054470A (en) 1988-03-02 1991-10-08 Laboratory Equipment, Corp. Ultrasonic treatment transducer with pressurized acoustic coupling
US5036855A (en) 1988-03-02 1991-08-06 Laboratory Equipment, Corp. Localization and therapy system for treatment of spatially oriented focal disease
US4951653A (en) 1988-03-02 1990-08-28 Laboratory Equipment, Corp. Ultrasound brain lesioning system
US4858613A (en) 1988-03-02 1989-08-22 Laboratory Equipment, Corp. Localization and therapy system for treatment of spatially oriented focal disease
US4955365A (en) 1988-03-02 1990-09-11 Laboratory Equipment, Corp. Localization and therapy system for treatment of spatially oriented focal disease
JP2615132B2 (en) * 1988-05-19 1997-05-28 富士通株式会社 Ultrasonic probe
US4947046A (en) * 1988-05-27 1990-08-07 Konica Corporation Method for preparation of radiographic image conversion panel and radiographic image conversion panel thereby
US5018508A (en) * 1988-06-03 1991-05-28 Fry Francis J System and method using chemicals and ultrasound or ultrasound alone to replace more conventional surgery
US4938217A (en) * 1988-06-21 1990-07-03 Massachusetts Institute Of Technology Electronically-controlled variable focus ultrasound hyperthermia system
US4938216A (en) * 1988-06-21 1990-07-03 Massachusetts Institute Of Technology Mechanically scanned line-focus ultrasound hyperthermia system
US4893624A (en) * 1988-06-21 1990-01-16 Massachusetts Institute Of Technology Diffuse focus ultrasound hyperthermia system
DE68923448T2 (en) * 1988-08-30 1995-12-07 Fujitsu Ltd COUPLER FOR ULTRASONIC TRANSDUCER PROBE.
US5159931A (en) * 1988-11-25 1992-11-03 Riccardo Pini Apparatus for obtaining a three-dimensional reconstruction of anatomic structures through the acquisition of echographic images
JPH0712362B2 (en) * 1989-02-17 1995-02-15 オリンパス光学工業株式会社 Ultrasonic therapy equipment
FR2643770B1 (en) * 1989-02-28 1991-06-21 Centre Nat Rech Scient MICROECHOGRAPHIC ULTRASONIC COLLIMATION PROBE THROUGH A DEFORMABLE SURFACE
DE69015400T2 (en) * 1989-03-27 1995-05-24 Toshiba Kawasaki Kk Mechanical ultrasound scanner.
DE3914619A1 (en) * 1989-05-03 1990-11-08 Kontron Elektronik DEVICE FOR TRANSOESOPHAGEAL ECHOCARDIOGRAPHY
US5057104A (en) 1989-05-30 1991-10-15 Cyrus Chess Method and apparatus for treating cutaneous vascular lesions
US5212671A (en) * 1989-06-22 1993-05-18 Terumo Kabushiki Kaisha Ultrasonic probe having backing material layer of uneven thickness
US5115814A (en) 1989-08-18 1992-05-26 Intertherapy, Inc. Intravascular ultrasonic imaging probe and methods of using same
US4973096A (en) * 1989-08-21 1990-11-27 Joyce Patrick H Shoe transporting device
JP2935519B2 (en) * 1989-08-28 1999-08-16 シーキンス,ケイ・マイケル Lung cancer hyperthermia treatment via convection with ultrasound and / or perfluorocarbon liquid
US5156144A (en) * 1989-10-20 1992-10-20 Olympus Optical Co., Ltd. Ultrasonic wave therapeutic device
ES2085885T3 (en) * 1989-11-08 1996-06-16 George S Allen MECHANICAL ARM FOR INTERACTIVE SURGERY SYSTEM DIRECTED BY IMAGES.
US5070879A (en) * 1989-11-30 1991-12-10 Acoustic Imaging Technologies Corp. Ultrasound imaging method and apparatus
CA2032204C (en) * 1989-12-14 1995-03-14 Takashi Mochizuki Three-dimensional ultrasonic scanner
US5209720A (en) * 1989-12-22 1993-05-11 Unger Evan C Methods for providing localized therapeutic heat to biological tissues and fluids using gas filled liposomes
US5149319A (en) * 1990-09-11 1992-09-22 Unger Evan C Methods for providing localized therapeutic heat to biological tissues and fluids
US5012797A (en) * 1990-01-08 1991-05-07 Montefiore Hospital Association Of Western Pennsylvania Method for removing skin wrinkles
JPH03251240A (en) * 1990-02-28 1991-11-08 Toshiba Corp Ultrasonic medical treatment device
JP3015481B2 (en) * 1990-03-28 2000-03-06 株式会社東芝 Ultrasonic probe system
JPH03297475A (en) * 1990-04-16 1991-12-27 Ken Ishihara Controlling method for emission of medicine by means of resonance sound wave
US5205287A (en) * 1990-04-26 1993-04-27 Hoechst Aktiengesellschaft Ultrasonic contrast agents, processes for their preparation and the use thereof as diagnostic and therapeutic agents
DE4117638A1 (en) * 1990-05-30 1991-12-05 Toshiba Kawasaki Kk SHOCK WAVE GENERATOR WITH A PIEZOELECTRIC ELEMENT
US5215680A (en) * 1990-07-10 1993-06-01 Cavitation-Control Technology, Inc. Method for the production of medical-grade lipid-coated microbubbles, paramagnetic labeling of such microbubbles and therapeutic uses of microbubbles
US5191880A (en) * 1990-07-31 1993-03-09 Mcleod Kenneth J Method for the promotion of growth, ingrowth and healing of bone tissue and the prevention of osteopenia by mechanical loading of the bone tissue
US5117832A (en) 1990-09-21 1992-06-02 Diasonics, Inc. Curved rectangular/elliptical transducer
JPH04150847A (en) * 1990-10-12 1992-05-25 Katsuya Takasu Armpit smell surgical apparatus and chip for operation
US5957882A (en) * 1991-01-11 1999-09-28 Advanced Cardiovascular Systems, Inc. Ultrasound devices for ablating and removing obstructive matter from anatomical passageways and blood vessels
US5997497A (en) * 1991-01-11 1999-12-07 Advanced Cardiovascular Systems Ultrasound catheter having integrated drug delivery system and methods of using same
US5255681A (en) * 1991-03-20 1993-10-26 Olympus Optical Co., Ltd. Ultrasonic wave diagnosing apparatus having an ultrasonic wave transmitting and receiving part transmitting and receiving ultrasonic waves
US5150714A (en) * 1991-05-10 1992-09-29 Sri International Ultrasonic inspection method and apparatus with audible output
JP3095835B2 (en) * 1991-10-30 2000-10-10 株式会社町田製作所 Gravity direction indicator for endoscopes
US5524620A (en) 1991-11-12 1996-06-11 November Technologies Ltd. Ablation of blood thrombi by means of acoustic energy
ATE144124T1 (en) * 1991-12-20 1996-11-15 Technomed Medical Systems DEVICE FOR ULTRASONIC THERAPY EMITTING SOUND WAVES, THERMAL EFFECTS AND CAVITATION EFFECTS
US5230334A (en) 1992-01-22 1993-07-27 Summit Technology, Inc. Method and apparatus for generating localized hyperthermia
AU3727993A (en) 1992-02-21 1993-09-13 Diasonics Inc. Ultrasound intracavity system for imaging therapy planning and treatment of focal disease
US5269297A (en) 1992-02-27 1993-12-14 Angiosonics Inc. Ultrasonic transmission apparatus
WO1993019705A1 (en) * 1992-03-31 1993-10-14 Massachusetts Institute Of Technology Apparatus and method for acoustic heat generation and hyperthermia
US5257970A (en) * 1992-04-09 1993-11-02 Health Research, Inc. In situ photodynamic therapy
US5295484A (en) * 1992-05-19 1994-03-22 Arizona Board Of Regents For And On Behalf Of The University Of Arizona Apparatus and method for intra-cardiac ablation of arrhythmias
DE4229817C2 (en) 1992-09-07 1996-09-12 Siemens Ag Method for the non-destructive and / or non-invasive measurement of a temperature change in the interior of a living object in particular
DE4302538C1 (en) 1993-01-29 1994-04-07 Siemens Ag Ultrasonic therapy device for tumour treatment lithotripsy or osteorestoration - with ultrasonic imaging and ultrasonic treatment modes using respective acoustic wave frequencies
US5267985A (en) * 1993-02-11 1993-12-07 Trancell, Inc. Drug delivery by multiple frequency phonophoresis
US20020169394A1 (en) * 1993-11-15 2002-11-14 Eppstein Jonathan A. Integrated tissue poration, fluid harvesting and analysis device, and method therefor
US5492126A (en) 1994-05-02 1996-02-20 Focal Surgery Probe for medical imaging and therapy using ultrasound
US5458596A (en) 1994-05-06 1995-10-17 Dorsal Orthopedic Corporation Method and apparatus for controlled contraction of soft tissue
US5694936A (en) * 1994-09-17 1997-12-09 Kabushiki Kaisha Toshiba Ultrasonic apparatus for thermotherapy with variable frequency for suppressing cavitation
US5520188A (en) * 1994-11-02 1996-05-28 Focus Surgery Inc. Annular array transducer
US5873902A (en) 1995-03-31 1999-02-23 Focus Surgery, Inc. Ultrasound intensity determining method and apparatus
US6241753B1 (en) 1995-05-05 2001-06-05 Thermage, Inc. Method for scar collagen formation and contraction
US6470216B1 (en) 1995-05-05 2002-10-22 Thermage, Inc. Method for smoothing contour irregularities of skin surface
US5660836A (en) 1995-05-05 1997-08-26 Knowlton; Edward W. Method and apparatus for controlled contraction of collagen tissue
US5755753A (en) 1995-05-05 1998-05-26 Thermage, Inc. Method for controlled contraction of collagen tissue
US5558092A (en) * 1995-06-06 1996-09-24 Imarx Pharmaceutical Corp. Methods and apparatus for performing diagnostic and therapeutic ultrasound simultaneously
WO1997017018A1 (en) 1995-11-09 1997-05-15 Brigham & Women's Hospital Aperiodic ultrasound phased array
US6350276B1 (en) 1996-01-05 2002-02-26 Thermage, Inc. Tissue remodeling apparatus containing cooling fluid
US6190323B1 (en) 1996-03-13 2001-02-20 Agielnt Technologies Direct contact scanner and related method
US5676692A (en) 1996-03-28 1997-10-14 Indianapolis Center For Advanced Research, Inc. Focussed ultrasound tissue treatment method
US5971949A (en) 1996-08-19 1999-10-26 Angiosonics Inc. Ultrasound transmission apparatus and method of using same
US5984882A (en) 1996-08-19 1999-11-16 Angiosonics Inc. Methods for prevention and treatment of cancer and other proliferative diseases with ultrasonic energy
US6216704B1 (en) 1997-08-13 2001-04-17 Surx, Inc. Noninvasive devices, methods, and systems for shrinking of tissues
US5820564A (en) * 1996-12-16 1998-10-13 Albatross Technologies, Inc. Method and apparatus for surface ultrasound imaging
US5904659A (en) 1997-02-14 1999-05-18 Exogen, Inc. Ultrasonic treatment for wounds
US5938612A (en) 1997-05-05 1999-08-17 Creare Inc. Multilayer ultrasonic transducer array including very thin layer of transducer elements
US5968034A (en) 1997-06-24 1999-10-19 Laser Aesthetics, Inc. Pulsed filament lamp for dermatological treatment
US6093883A (en) 1997-07-15 2000-07-25 Focus Surgery, Inc. Ultrasound intensity determining method and apparatus
US20020169442A1 (en) 1997-08-12 2002-11-14 Joseph Neev Device and a method for treating skin conditions
US6413253B1 (en) 1997-08-16 2002-07-02 Cooltouch Corporation Subsurface heating of material
US6113558A (en) 1997-09-29 2000-09-05 Angiosonics Inc. Pulsed mode lysis method
US6049159A (en) * 1997-10-06 2000-04-11 Albatros Technologies, Inc. Wideband acoustic transducer
US6623430B1 (en) 1997-10-14 2003-09-23 Guided Therapy Systems, Inc. Method and apparatus for safety delivering medicants to a region of tissue using imaging, therapy and temperature monitoring ultrasonic system
US6500121B1 (en) 1997-10-14 2002-12-31 Guided Therapy Systems, Inc. Imaging, therapy, and temperature monitoring ultrasonic system
US6050943A (en) * 1997-10-14 2000-04-18 Guided Therapy Systems, Inc. Imaging, therapy, and temperature monitoring ultrasonic system
US6071239A (en) 1997-10-27 2000-06-06 Cribbs; Robert W. Method and apparatus for lipolytic therapy using ultrasound energy
US6007499A (en) 1997-10-31 1999-12-28 University Of Washington Method and apparatus for medical procedures using high-intensity focused ultrasound
US6325769B1 (en) * 1998-12-29 2001-12-04 Collapeutics, Llc Method and apparatus for therapeutic treatment of skin
US20020040199A1 (en) 1997-12-29 2002-04-04 Klopotek Peter J. Method and apparatus for therapeutic treatment of skin
US6113559A (en) 1997-12-29 2000-09-05 Klopotek; Peter J. Method and apparatus for therapeutic treatment of skin with ultrasound
DE19800416C2 (en) 1998-01-08 2002-09-19 Storz Karl Gmbh & Co Kg Device for the treatment of body tissue, in particular soft tissue close to the surface, by means of ultrasound
US20020055702A1 (en) 1998-02-10 2002-05-09 Anthony Atala Ultrasound-mediated drug delivery
US6685640B1 (en) 1998-03-30 2004-02-03 Focus Surgery, Inc. Ablation system
US6036646A (en) * 1998-07-10 2000-03-14 Guided Therapy Systems, Inc. Method and apparatus for three dimensional ultrasound imaging
US6443914B1 (en) 1998-08-10 2002-09-03 Lysonix, Inc. Apparatus and method for preventing and treating cellulite
JP4460691B2 (en) * 1998-09-30 2010-05-12 株式会社東芝 Ultrasonic therapy device
JP4095729B2 (en) 1998-10-26 2008-06-04 株式会社日立製作所 Therapeutic ultrasound system
WO2000030554A1 (en) * 1998-11-20 2000-06-02 Jones Joie P Methods for selectively dissolving and removing materials using ultra-high frequency ultrasound
US6428532B1 (en) * 1998-12-30 2002-08-06 The General Hospital Corporation Selective tissue targeting by difference frequency of two wavelengths
US6183773B1 (en) 1999-01-04 2001-02-06 The General Hospital Corporation Targeting of sebaceous follicles as a treatment of sebaceous gland disorders
US6200308B1 (en) 1999-01-29 2001-03-13 Candela Corporation Dynamic cooling of tissue for radiation treatment
JP4406107B2 (en) * 1999-03-09 2010-01-27 株式会社東芝 Ultrasonic therapy device
US6408212B1 (en) 1999-04-13 2002-06-18 Joseph Neev Method for treating acne
US6217530B1 (en) * 1999-05-14 2001-04-17 University Of Washington Ultrasonic applicator for medical applications
US20030216795A1 (en) 1999-07-07 2003-11-20 Yoram Harth Apparatus and method for high energy photodynamic therapy of acne vulgaris, seborrhea and other skin disorders
US6451007B1 (en) 1999-07-29 2002-09-17 Dale E. Koop Thermal quenching of tissue
US6440071B1 (en) * 1999-10-18 2002-08-27 Guided Therapy Systems, Inc. Peripheral ultrasound imaging system
US6626855B1 (en) 1999-11-26 2003-09-30 Therus Corpoation Controlled high efficiency lesion formation using high intensity ultrasound
WO2001045550A2 (en) 1999-12-23 2001-06-28 Therus Corporation Ultrasound transducers for imaging and therapy
US6436061B1 (en) 1999-12-29 2002-08-20 Peter D. Costantino Ultrasound treatment of varicose veins
US6413254B1 (en) 2000-01-19 2002-07-02 Medtronic Xomed, Inc. Method of tongue reduction by thermal ablation using high intensity focused ultrasound
US6692450B1 (en) 2000-01-19 2004-02-17 Medtronic Xomed, Inc. Focused ultrasound ablation devices having selectively actuatable ultrasound emitting elements and methods of using the same
US6409720B1 (en) 2000-01-19 2002-06-25 Medtronic Xomed, Inc. Methods of tongue reduction using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions
US6595934B1 (en) 2000-01-19 2003-07-22 Medtronic Xomed, Inc. Methods of skin rejuvenation using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions
US6361531B1 (en) 2000-01-21 2002-03-26 Medtronic Xomed, Inc. Focused ultrasound ablation devices having malleable handle shafts and methods of using the same
US6428477B1 (en) * 2000-03-10 2002-08-06 Koninklijke Philips Electronics, N.V. Delivery of theraputic ultrasound by two dimensional ultrasound array
US6790187B2 (en) * 2000-08-24 2004-09-14 Timi 3 Systems, Inc. Systems and methods for applying ultrasonic energy
JP2001170068A (en) * 2000-10-16 2001-06-26 Toshiba Corp Ultrasonic treatment instrument
US6645162B2 (en) 2000-12-27 2003-11-11 Insightec - Txsonics Ltd. Systems and methods for ultrasound assisted lipolysis
US6626854B2 (en) 2000-12-27 2003-09-30 Insightec - Txsonics Ltd. Systems and methods for ultrasound assisted lipolysis
US6540679B2 (en) 2000-12-28 2003-04-01 Guided Therapy Systems, Inc. Visual imaging system for ultrasonic probe
CA2433022C (en) 2000-12-28 2016-12-06 Palomar Medical Technologies, Inc. Method and apparatus for therapeutic emr treatment of the skin
US7347855B2 (en) 2001-10-29 2008-03-25 Ultrashape Ltd. Non-invasive ultrasonic body contouring
US6607498B2 (en) 2001-01-03 2003-08-19 Uitra Shape, Inc. Method and apparatus for non-invasive body contouring by lysing adipose tissue
US6932771B2 (en) 2001-07-09 2005-08-23 Civco Medical Instruments Co., Inc. Tissue warming device and method
US7018396B2 (en) 2001-08-07 2006-03-28 New England Medical Center Hospitals, Inc. Method of treating acne
US20030032900A1 (en) 2001-08-08 2003-02-13 Engii (2001) Ltd. System and method for facial treatment
US7094252B2 (en) 2001-08-21 2006-08-22 Cooltouch Incorporated Enhanced noninvasive collagen remodeling
US7258674B2 (en) 2002-02-20 2007-08-21 Liposonix, Inc. Ultrasonic treatment and imaging of adipose tissue
US6887239B2 (en) 2002-04-17 2005-05-03 Sontra Medical Inc. Preparation for transmission and reception of electrical signals
AU2003261073A1 (en) 2002-05-16 2003-12-02 Barbara Ann Karmanos Cancer Institute Combined diagnostic and therapeutic ultrasound system
US7179238B2 (en) 2002-05-21 2007-02-20 Medtronic Xomed, Inc. Apparatus and methods for directly displacing the partition between the middle ear and inner ear at an infrasonic frequency
US20030191396A1 (en) 2003-03-10 2003-10-09 Sanghvi Narendra T Tissue treatment method and apparatus
US7273459B2 (en) 2003-03-31 2007-09-25 Liposonix, Inc. Vortex transducer
US20040206365A1 (en) 2003-03-31 2004-10-21 Knowlton Edward Wells Method for treatment of tissue
CN1901837B (en) * 2003-12-30 2010-05-12 利普索尼克斯股份有限公司 Component ultrasound transducer
US20050154332A1 (en) * 2004-01-12 2005-07-14 Onda Methods and systems for removing hair using focused acoustic energy
WO2005074365A2 (en) * 2004-02-06 2005-08-18 Technion Research And Development Foundation Ltd. Localized production of microbubbles and control of cavitational and heating effects by use of enhanced ultrasound
US7553284B2 (en) * 2005-02-02 2009-06-30 Vaitekunas Jeffrey J Focused ultrasound for pain reduction

Also Published As

Publication number Publication date
KR20110091830A (en) 2011-08-12
US7530958B2 (en) 2009-05-12
ES2629301T3 (en) 2017-08-08
US20090216159A1 (en) 2009-08-27
JP2014087679A (en) 2014-05-15
IL181892A0 (en) 2007-07-04
EP3257554A1 (en) 2017-12-20
IL181892A (en) 2010-12-30
JP2012050845A (en) 2012-03-15
US20060074355A1 (en) 2006-04-06
EP1809377A1 (en) 2007-07-25
KR101269918B1 (en) 2013-05-31
JP2008514294A (en) 2008-05-08
HK1248630A1 (en) 2018-10-19
JP2016195801A (en) 2016-11-24
JP5485967B2 (en) 2014-05-07
KR20070065332A (en) 2007-06-22
CA2580561C (en) 2014-11-04
CA2860065C (en) 2017-11-07
EP1809377B1 (en) 2017-04-12
CA2580561A1 (en) 2006-04-06
WO2006036870A1 (en) 2006-04-06

Similar Documents

Publication Publication Date Title
CA2860065C (en) Method and system for combined ultrasound treatment
US10888717B2 (en) Probe for ultrasound tissue treatment
US11097133B2 (en) Method and system for combined energy therapy profile
US7530356B2 (en) Method and system for noninvasive mastopexy
KR20110101204A (en) Methods and systems for fat reduction and/or cellulite treatment
EP2152367B1 (en) System for combined energy therapy profile

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20150206